Orphan Reach is extremely honoured to be part of this crucial Phase II COVID-19 trial at the forefront of clinical research. We are delighted to be […]
Orphan Reach today announced that regulatory approval has been obtained for Vicore Pharma’s Phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 […]
There are some changes in the data protection law, so we wanted you to know that we've updated our Privacy Policy. Your trust is important to us, and we want to make sure you understand what these changes mean for you.
Please visit our Privacy Policy page for more information about our Privacy and Cookie Policy.